Aiforia Technologies Oyj

AIFORIA

FI4000507934

Software

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2025-07-07 EDT			After hours 15:59:59
3.310 ^EUR	+1.22%		3.265	-1.36%

06-24	Aiforia Releases New CE-IVD-Marked Clinical AI Solution for Breast Cancer Diagnostics	CI
05-26	Aiforia Technologies Appoints Richard Doughty as Medical Director	CI

Orion to Use Aiforia's Software for Preclinical Histology

Published on 2025-03-05 at 03:28, updated on 2025-03-05 at 03:29

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Aiforia Technologies Oyj

Aiforia Releases New CE-IVD-Marked Clinical AI Solution for Breast Cancer Diagnostics	06-24	CI
Aiforia Technologies Appoints Richard Doughty as Medical Director	05-26	CI
Aiforia Technologies Enters Clinical AI Partnership Deal in France	05-19	MT
The Nantes University Hospital Selects Aiforia Technologies plc as Partner for Ai-Assisted Diagnostics in Pathology	05-19	CI
Aiforia Technologies Oyj Announces Resignation of Tuomas Ropponen, Chief Technology Officer and Member of Management Team	05-08	CI
Aiforia Technologies Oyj Approves Board Appointments	04-04	CI
Aiforia Technologies Plc Announces Thomas Westerling-Bui Leaves as Chief Commercial Officer of Americas and Member of Management Team, Effective March 31, 2025	04-01	CI
Aiforia and Uscap Extend Collaboration to Support E Learning for Pathologists	03-24	CI
Aiforia Technologies to Deploy AI Image System for Pathologists via PathPresenter Tie-up	03-21	MT
Aiforia Technologies, Techcyte Team Up for AI Digital Pathology Platform	03-21	MT
Aiforia Partners with Quorum Technologies to Expand in Canada	03-18	MT
Aiforia Technologies Expands Its Global Reach Through Partnership with Quorum Technologies in Canada	03-18	CI
Aiforia Technologies Oyj, 2024 Earnings Call, Mar 07, 2025	03-07
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2024	03-07	CI
Aiforia Technologies Closes Deal With Regional Health Authority Of Sardinia In Italy	03-06	RE
Orion to Use Aiforia's Software for Preclinical Histology	03-05	MT
Orion Corporation and Aiforia Technologies plc Extend Collaboration to Preclinical Study Evaluation	03-05	CI
Aiforia Technologies Gains In Vitro Diagnostic Regulation Certification	02-20	MT
Aiforia Technologies Oyj Secures IVDR Certification, Pending the Way for Expanded Clinical Portfolio in Europe	02-20	CI
Aiforia Technologies Plc Selects to Provide AI-Assisted Diagnostic Solutions to Regional Health Authorities in Italy	01-24	CI
Memorial Hospitals Group in Turkey Selects Aiforia as the Partner for Ai-Assisted Clinical Diagnostics in Pathology	12-02	CI
Certain Shares of Aiforia Technologies Oyj are subject to a Lock-Up Agreement Ending on 18-NOV-2024.	11-17	CI
Aiforia Technologies, Paige Partner to Integrate AI in Pathology Labs	11-04	MT
Aiforia and Paige Forms Strategic Partnership to Advance AI Integration in Pathology Laboratories	11-04	CI
Aiforia Technologies Joins NIH STRIDES Google Marketplace as AI Solution Provider	24-10-17	CI

Chart Aiforia Technologies Oyj

Duration

Period

AIFORIA: Dynamic Chart

Aiforia Technologies Oyj is a Finland-based company providing image analysis software utilizing artificial intelligence (AI). Aiforiaâs business model is based on the development and utilization of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics. The Companyâs cloud-based deep learning artificial intelligence solutions aim to increase the speed, accuracy, and consistency of analyzing medical images across a wide range of fields. Aiforia's solutions aim to automate routine tasks and provide artificial intelligence to support the diagnostic workflow. The product offering consists of Aiforia Create, a solution with which the end user can develop their own AI model for any image analysis application simply by annotating images to train the AI model what to identify, quantify, or measure.

Employees

Sector

Software

Calendar

08-28 - Q2 2025 Earnings Release

More about the company